Generic Naprelan

The earliest that a generic for Naprelan could be available is 2014, when the patent for Naprelan expires. Drugs that are currently advertised as generic Naprelan are substandard and potentially dangerous. Until an approved generic for Naprelan is available, do not buy any generic Naprelan.

 

Generic Naprelan: An Overview

Naprelan® (naproxen sodium) is a medication that has been licensed to treat several conditions. Some Naprelan uses include:
 
  • Pain relief. Naprelan can relieve pain following a procedure, as well as pain caused by a strained muscle or inflammation in a tendon (tendonitis) or bursa (bursitis). It can also be used to treat general pain, such as knee pain, lower back pain, or neck pain.
     
  • Treatment of arthritis symptoms, including pain, stiffness, and swelling. Naprelan can be used to treat several different types of arthritis, including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and gout. Naprelan does not cure these types of arthritis.
     
  • Treatment of painful menstrual periods.
     
Naprelan is manufactured by Blansett Pharmacal, Inc. and is currently protected by a patent that prevents any generic Naprelan from being manufactured. If you see generic Naprelan available, be cautious. The fact is that these medicines are fake, substandard, and potentially dangerous. You should not buy any generic Naprelan until there is an approved version available.
 

When Will There Be a Generic Naprelan?

The patent for Naprelan currently expires in 2014. It is expected that once Naprelan goes off patent, several companies will begin manufacturing a generic Naprelan drug. Normally in the United States, one company is given 180 days of exclusivity to manufacture a generic version. After 180 days, it would be expected that a number of other manufacturers of generic medications will also begin making a generic Naprelan.
 
(Generic Naprelan Continued: Page 2)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;